Bread Financial Schedules First Quarter 2026 Earnings Conference Call for Apr. 23

COLUMBUS, Ohio, April 07, 2026 (GLOBE NEWSWIRE) -- Bread Financial^® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions will host a conference call on Thursday, Apr. 23, 2026, at 8:30 a.m. ET to discuss the company’s first quarter 2026 results.

Conference Call/Webcast Information
Participants can register in advance here, and the conference call will be available at the company’s investor relations website. Analysts planning to participate in the Q&A can register in advance here. Additionally, there will be several slides accompanying the webcast. Please go to the website at least 15 minutes prior to the call to register, as well as download and install any necessary software. The webcast will also be archived on the investor relations website.

About Bread Financial^®
Bread Financial^® (NYSE: BFH) is a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions to millions of U.S. consumers. Our payment solutions deliver growth for some of the most recognized brands in travel & entertainment, health & beauty, technology, electronics, jewelry, home and specialty apparel through our co-brand and private label credit cards and pay-over-time products providing choice and value to our shared customers. Additionally, we offer Bread Financial general purpose credit cards and saving products that empower our customers and their passions for a better life.

Bread Financial proudly marks 30 years of success in 2026. To learn more about our global associates, our performance and our sustainability progress, visit breadfinancial.com or follow us on Instagram and LinkedIn.

Contacts
Brian Vereb — Investor Relations
[email protected]

Susan Haugen – Investor Relations
[email protected]

Rachel Stultz — Media
[email protected]  

You May Also Be Interested In

• Bread Financial Schedules Second Quarter 2026 Earnings Conference Call for Jul. 23
• Stolt-Nielsen Limited Reports Unaudited Results For the Second Quarter and First Half of 2026
• Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.